Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 5 of 5 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/01/24
End: 08/01/28
Due: 08/01/29
Phase: N/A
Priority: Normal
Start: 08/06/21
End: 01/01/26
Due: 01/01/27
Phase: N/A
Priority: Normal
Start: 01/01/15
End: 08/31/21
Due: 08/31/22
Phase: N/A
Priority: Normal
Start: 05/01/14
End: 01/31/24
Due: 01/31/25
Phase: N/A
Priority: Normal
Start: 03/25/22
End: 08/25/24
Due: 08/25/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Clinical Study of Active Intervention in High-risk HFpEF Patients | NCT06532019 | Xiangtan Central Hospital | user2@example.com | None | 2024-08-01 | 2028-08-01 | 2029-08-01 | - | - | 2025-07-14 |
| Association Between Dapagliflozin-induced Improvement and Anemia in Heart Failure Patients (ADIDAS) | NCT04707261 | Xiangtan Central Hospital | user2@example.com | None | 2021-08-06 | 2026-01-01 | 2027-01-01 | - | - | 2025-07-14 |
| Outcome of Discharged HFmrEF Patients | NCT05240118 | Xiangtan Central Hospital | user2@example.com | None | 2015-01-01 | 2021-08-31 | 2022-08-31 | - | - | 2025-07-14 |
| Risk Factors In Heart Failure Patients With Preserved Ejection Fraction | NCT06487468 | Xiangtan Central Hospital | user2@example.com | None | 2014-05-01 | 2024-01-31 | 2025-01-31 | - | - | 2025-07-14 |
| B-lines-guided Heart Failure Management in Heart Failure Patients | NCT05035459 | Xiangtan Central Hospital | user2@example.com | None | 2022-03-25 | 2024-08-25 | 2025-08-25 | - | - | 2025-07-14 |